alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
---



EXHIBIT 31.1

CERTIFICATIONS

I, Arthur D. Levinson, certify that:

1.   I have reviewed this annual report on Form 10-K of Genentech, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c)   Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





|Date: | February 27, 2004 |  | By: | /s/ARTHUR D. LEVINSON                                          
|----- | ----------------- |  | --- | ---------------------------------------------------------------
|      |                   |  |     |                                                                
|      |                   |  |     | Arthur D. Levinson, Ph.D.
President and Chief Executive Officer

---
19.502-9 Withdrawing or modifying small business set-asides. ( a ) If, before award of a contract involving a total or partial small business set-aside, the contracting officer considers that award would be detrimental to the public interest (e.g., payment of more than a fair market price), the contracting officer may withdraw the small business set-aside, whether it was unilateral or joint. The contracting officer shall initiate a withdrawal of an individual total or partial small business set-aside, by giving written notice to the agency small business specialist and the SBA PCR (or, if a PCR is not assigned, see 19.402(a)) stating the reasons. In a similar manner, the contracting officer may modify a unilateral or joint class small business set-aside to withdraw one or more individual acquisitions.
( b ) If the agency small business specialist does not agree to a withdrawal or modification, the case shall be promptly referred to the SBA PCR (or, if a PCR is not assigned, see 19.402(a)) for review.
( c ) The contracting officer shall prepare a written statement supporting any withdrawal or modification of a small business set-aside and include it in the contract file.
[60 FR 48262, Sept. 18, 1995, as amended at 63 FR 70270, Dec. 18, 1998; 71 FR 36926, June 28, 2006. Redesignated and amended at 85 FR 11762, Feb. 27, 2020]
#### Stephens *v.*The State.

March 11, 1913.

Indictment for murder. Before Judge Rawlings. Jefferson superior court. December 12, 1912.

*John B. Cooper,*for plaintiff in error.

*Thomas 8. Felder, attorney-general, B. Lee Moore, solicitor-general,*and *Alfred Herrington,*contra.

Ltjmpkin,'J.

1. Voluntary drunkenness furnishes no excuse for murder. Penal Code, § 39; *Strickland*v. *State,*137 *Ga.*115, 116 (72 S. E. 922).

2. Neither the evidence nor the statement of the accused involved the offense of manslaughter, and there was no error in refusing a request to charge on that subject.

3. Nor did they involve any question of defense of one’s habitation against a forcible attack and invasion on his property or habitation by another, under the Penal Code, § 72.

4. Nothing in the evidence or statement authorized the submission of the question óf a necessity to slay the deceased as a protection against a trespasser’, or the right to use necessary force to eject a trespasser without retreating.

5. The evidence supported the verdict, and there was no error in overruling the motion for a new trial.

*Judgment affirmed.*

*Beoh, J., absent. The other Justices concur.*
#### 1305.404 Release of long-range acquisition estimates.
<PAGE>

                                 EXHIBIT 21

                  GAMMA BIOLOGICALS, INC. AND SUBSIDIARIES
                       SUBSIDIARIES OF THE REGISTRANT


                                        State or Country
                                            in which          Percent
                                          Incorporated         Owned
                                        ----------------      -------
Registrant:
  Gamma Biologicals, Inc.                     Texas        Not Applicable
Subsidiaries of the Registrant(A):
  Delta Diagnostics, Inc.                     Texas             100%
  Gamma Biologicals International, Inc.   United States
                                          Virgin Islands        100%
  Gamma Biologicals, B.V.                 The Netherlands       100%

-------------
Note A   All of the subsidiaries are included in the consolidated financial
         statements of the Registrant.
20-F











Exhibit 10.11  




Consent of Independent
Registered Public Accounting Firm 



We consent to the incorporation by
reference in the Registration Statements on Form S-8 (Registration Nos. 333-127097 and
333-101979) and on Form F-3 (Registration Nos. 333-128138 and 333-122236) of our report
dated March 29, 2006, with respect to the consolidated financial statements of TTI Team
Telecom International Ltd., included in this Annual Report on Form 20-F for the year ended
December 31, 2005. 



	April 11, 2006
Tel-Aviv, Israel		Yours Truly,



/s/  KOST FORER GABBAY &KASIERER
KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global
(December 22, 1960)

#### Rose Glazer, Respondent, v. Abraham M. Glazer, Appellant.

Motion by appellant for a stay granted to the extent of staying, pending appeal, enforcement of the order appealed from dated September 28,1960, and motion otherwise denied, without prejudice to any subsequent motion by appellant for a stay, if so advised, in the event the pending motion for sequestration be decided adversely to him and in the event that he appeals from the order entered thereon. The present motion for a stay is granted on condition that appellant perfect the pending appeal and be ready to argue or submit it on January 13, 1961. The appeal is ordered on the calendar for that day. The record and appellant’s brief must be served and filed on or before January 9, 1961. Beldock, Acting P. J., Ughetta, Kleinfeld, Christ and Pette, JJ., concur.
<PAGE>



                                                                  Exhibit 10(b)

                                 REPRESENTATION OF COUNSEL



I, Sandra M. DaDalt, in my capacity as counsel to Sun Life of Canada (U.S.)
Variable Account F (the "Account") have reviewed this Post-Effective
Amendment to the Registration Statement of the Account which is being filed
pursuant to paragraph (b) of Rule 485 under the Securities Act of 1933. Based
on my review of this Post-Effective Amendment and such other material
relating to the operations of the Account as I deemed relevant, I hereby
certify as of the date of filing this Post-Effective Amendment, that the
Post-Effective Amendment does not contain disclosure which would render it
ineligible to become effective pursuant to paragraph (b) of Rule 485.

I hereby consent to the filing of this representation as part of this
Post-Effective Amendment to the Registration Statement of the Account.

                                         /s/ SANDRA M. DADALT
                                         -----------------------
                                         Sandra M. DaDalt, Esq.

April 19, 2000
<PAGE>
                                                                    Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Byron L. Bergren, President and Chief Executive Officer of The Elder-Beerman
Stores Corp., (the "Company"), do hereby certify in accordance with 18. U.S.C.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:

         The Quarterly Report on Form 10-Q of the Company for the period ending
         August 2, 2003 (the "Periodic Report") fully complies with the
         requirement of section 13 (a) or 15 (d) of the Securities Exchange Act
         of 1934 (15 U.S.C. 78m or 78o(d)) and

         The information contained in the Periodic Report fairly present, in all
         material respects, the financial condition and results of operation of
         the Company.

Dated:  September 15, 2003

                                        /s/ Byron L. Bergren
                                        -------------------------------------
                                        Byron L. Bergren
                                        President and Chief Executive Officer
#### Richard Wright, Appellant, v Silver Shore Construction Co., Inc., Respondent. Rosemarie Wright, Appellant, v Silver Shore Construction Co., Inc., Respondent.

— Judgment unanimously affirmed, without costs (see *Fey v Stengle,*67 AD2d 831). (Appeal from judgment of Monroe Supreme Court — dismiss complaints.) Present — Dillon, P. J., Simons, Hancock, Jr., Callahan and Moule, JJ.
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 1 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 2 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 3 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 4 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 5 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 6 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 7 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 8 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 9 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 10 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 11 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 12 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 13 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 14 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 15 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 16 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 17 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 18 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 19 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 20 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 21 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 22 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 23 of 24 PageID #:6260
Case: 1:11-cv-07972 Document #: 405-1 Filed: 01/14/19 Page 24 of 24 PageID #:6260
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         122,017
<INT-BEARING-DEPOSITS>                          34,735
<FED-FUNDS-SOLD>                                39,168
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    399,057
<INVESTMENTS-CARRYING>                         425,252
<INVESTMENTS-MARKET>                           420,788
<LOANS>                                      1,773,702
<ALLOWANCE>                                     22,816
<TOTAL-ASSETS>                               2,920,138
<DEPOSITS>                                   2,460,159
<SHORT-TERM>                                   116,855
<LIABILITIES-OTHER>                             23,330
<LONG-TERM>                                     28,176
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        44,685
<OTHER-SE>                                     246,933
<TOTAL-LIABILITIES-AND-EQUITY>               2,920,138
<INTEREST-LOAN>                                 74,580
<INTEREST-INVEST>                               23,352
<INTEREST-OTHER>                                 2,687
<INTEREST-TOTAL>                               100,619
<INTEREST-DEPOSIT>                              36,468
<INTEREST-EXPENSE>                               2,536
<INTEREST-INCOME-NET>                           61,615
<LOAN-LOSSES>                                    2,021
<SECURITIES-GAINS>                               3,113
<EXPENSE-OTHER>                                 52,135
<INCOME-PRETAX>                                 31,986
<INCOME-PRE-EXTRAORDINARY>                      31,986
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    20,597
<EPS-BASIC>                                       0.92
<EPS-DILUTED>                                     0.91
<YIELD-ACTUAL>                                    4.69
<LOANS-NON>                                     10,197
<LOANS-PAST>                                     2,621
<LOANS-TROUBLED>                                   218
<LOANS-PROBLEM>                                 15,110
<ALLOWANCE-OPEN>                                22,646
<CHARGE-OFFS>                                    2,258
<RECOVERIES>                                       407
<ALLOWANCE-CLOSE>                               22,816
<ALLOWANCE-DOMESTIC>                            22,816
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
19.1306 HUBZone sole-source awards. ( a ) A contracting officer shall consider a contract award to a HUBZone small business concern on a sole-source basis (see 6.302-5(b)(5)) before considering a small business set-aside (see 19.203 and subpart 19.5), provided none of the exclusions at 19.1304 apply; and— ( 1 ) The contracting officer does not have a reasonable expectation that offers would be received from two or more HUBZone small business concerns;
( 2 ) The anticipated price of the contract, including options, will not exceed— ( i ) $7 million for a requirement within the North American Industry Classification System (NAICS) codes for manufacturing; or
( ii ) $4.5 million for a requirement within all other NAICS codes;
( 3 ) The requirement is not currently being performed by an 8(a) participant under the provisions of subpart 19.8 or has been accepted as a requirement by SBA under subpart 19.8.
( 4 ) The HUBZone small business concern has been determined to be a responsible contractor with respect to performance; and
( 5 ) Award can be made at a fair and reasonable price.
( b ) The SBA has the right to appeal the contracting officer's decision not to make a HUBZone sole-source award (see 13 CFR 126.610).
[63 FR 70272, Dec. 18, 1998, as amended at 65 FR 46057, July 26, 2000; 68 FR 4051, Jan. 27, 2003; 69 FR 8315, Feb. 23, 2004; 71 FR 57367, Sept. 28, 2006; 75 FR 38688, July 2, 2010; 75 FR 53133, Aug. 30, 2010; 75 FR 77731, Dec. 13, 2010; 76 FR 14568, Mar. 16, 2011; 77 FR 12932, Mar. 2, 2012; 80 FR 38298, July 2, 2015; 85 FR 62489, Oct. 2, 2020; 86 FR 61041, Nov. 4, 2021; 87 FR 58236, Sept. 23, 2022]
[FILED  IN  THE
OFFICE  OF  THE
SECRETARY  OF  STATE  OF
THE  STATE  OF  NEVADA]

OCT  20  1999
NO.  C1407-80
/s/  Dean  Heller
DEAN  HELLER,  SECRETARY  OF  STATE



                         ARTICLES  OF  AMENDMENT

                                   OF
                        ARTICLES OF INCORPORATION

                                   OF

                   ASSOCIATED  MEDICAL  DEVICES,  INC.

     We  the undersigned, President and Secretary of Associated Medical Devices,
Inc.  hereby  certify:

     That the Board of Directors of said corporation at a meeting duly convened,
held  on  the  18th  day  of  October,  1999,  adopted a resolution to amend the
original  articles  of  incorporation  as  follows:

     1.  ARTICLE  I  of  the  Corporation's  Articles of Incorporation is hereby
amended  to  read  as  follows:

          "1.  The  name  of  the  Corporation  is  YourNet,  Inc."

     2.  The  number  of  shares  of the corporation outstanding and entitled to
vote  on  an  amendment  to the Articles of Incorporation is 5,844,238; that the
said  amendment  has  been  consented  to and approved by a majority vote of the
stockholders  holding at least a majority of each class of stock outstanding and
entitled  to  vote  thereon.

     4.  This  Amendment  shall  be  effective  upon  filing.

     IN  WITNESS  WHEREOF,  the  Corporation  has  caused  this  Certificate  of
Amendment  to  be signed by its President, John Huguet, and its Secretary, Randy
Dotten,  this  18th  day  of  October,  1999.

                              /s/  John  Huguet
                                   John  Huguet,  President



                              /s/  Randy  Dotten
                                   Randy  Dotten,  Secretary
Exhibit 32(b)



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of Ethyl Corporation (the Company) for the period ending June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, David A. Fiorenza, chief financial officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that:



(1)    the Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.



|                                                            | 
|----------------------------------------------------------- | 
|By:                                                         | 
|David A. FiorenzaVice President and TreasurerAugust 8, 2003



A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to
Ethyl Corporation and will be retained by Ethyl Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-28-1998
<PERIOD-START>                             MAR-30-1997
<PERIOD-END>                               MAR-28-1998
<CASH>                                         710,000
<SECURITIES>                                         0
<RECEIVABLES>                                1,851,000
<ALLOWANCES>                                    32,000
<INVENTORY>                                  2,073,000
<CURRENT-ASSETS>                             4,697,000
<PP&E>                                       4,321,000
<DEPRECIATION>                               3,587,000
<TOTAL-ASSETS>                               5,450,000
<CURRENT-LIABILITIES>                        2,280,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                        2,583,000
<PREFERRED>                                          0
<COMMON>                                     3,107,000
<OTHER-SE>                                  31,269,000
<TOTAL-LIABILITY-AND-EQUITY>                 5,450,000
<SALES>                                     16,854,000
<TOTAL-REVENUES>                            16,854,000
<CGS>                                        9,303,000
<TOTAL-COSTS>                               15,851,000
<OTHER-EXPENSES>                               (5,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              41,000
<INCOME-PRETAX>                                967,000
<INCOME-TAX>                                    30,000
<INCOME-CONTINUING>                            937,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   937,000
<EPS-PRIMARY>                                     0.03
<EPS-DILUTED>                                     0.03
        

</TABLE>